The most common type of CTCL is mycosis fungoides (MF). Mycosis fungoides was so named by a French dermatologist in the 1800s due to the mushroom like tumors that developed on the skin of a ...

A new research paper titled "GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells" has been published in Oncotarget. In this new study, researchers Michael R. Booth, Laurence Booth ...

US FDA grants breakthrough therapy designation to Innate Pharma’s lacutamab for relapsed or refractory Sézary syndrome: Marseille, France Tuesday, February 18, 2025, 12:00 Hrs ...

Innate Pharma has secured US Food and Drug Administration (FDA) breakthrough therapy designation for lacutamab to treat ...

Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma. It is characterized by malignant T-cell lymphocytes in the skin. It presents as patch, plaque, or tumor stage and is ...

Considering taking supplements to treat mycosis fungoides? Below is a list of common natural remedies used to treat or reduce the symptoms of mycosis fungoides. Follow the links to read common ...

Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.